Evidence map›Paper›PMID 24324951›Full record

ArticleBioMed research international2013

Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels.

Manel Luján, Xavier Gallardo, María José Amengual, Montserrat Bosque, Rosa M Mirapeix, Christian Domingo

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management.American journal of respiratory and critical care medicine · 2020
    Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis.Tuberculosis and respiratory diseases · 2024
    Article
  9. Article
  10. Article
  11. Airway disease in hematologic malignancies.Expert review of respiratory medicine · 2022
    Review
  12. Article
  13. Review
  14. Clinical and Radiological Phenotypes and Endotypes.Seminars in respiratory and critical care medicine · 2021
    Article
  15. Article
  16. Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
  17. Article
  18. Children with chronic lung diseases have cognitive dysfunction as assessed by event-related potential (auditory P300) and Stanford-Binet IQ (SB-IV) test.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Manel LujánServei de Pneumologia, Hospital de Sabadell, Corporació Sanitària i Universitària Parc Taulí, Parc Taulí 1, Sabadell, 08208 Barcelona, Spain ; Departament de Medicina, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Cerdanyola del Vallès, 08193 Barcelona, Spain ; Ciber de Enfermedades Respiratorias (CIBERES), Carretera Soller Km 12, Illes Balears, 07110 Bunyola, Spain.
Xavier Gallardo
María José Amengual
Montserrat Bosque
Rosa M Mirapeix
Christian Domingo
Corporació Sanitària Parc Taulí · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo establish the prevalence of bronchiectasis in asthma in relation to patients' oral corticosteroid requirements and to explore whether the increased risk is due to blood immunoglobulin (Ig) concentration.

methodsCase-control cross-sectional study, including 100 sex- and age-matched patients, 50 with non-steroid-dependent asthma (NSDA) and 50 with steroid-dependent asthma (SDA). STUDY PROTOCOL: (a) measurement of Ig and gG subclass concentration; (b) forced spirometry; and (c) high-resolution thoracic computed tomography. When bronchiectasis was detected, a specific etiological protocol was applied to establish its etiology.

resultsThe overall prevalence of bronchiectasis was 12/50 in the SDA group and 6/50 in the NSDA group (p = ns). The etiology was documented in six patients (four NSDA and two SDA). After excluding these patients, the prevalence of bronchiectasis was 20% (10/50) in the SDA group and 2/50 (4%) in the NSDA group (P < 0.05). Patients with asthma-associated bronchiectasis presented lower FEV1 values than patients without bronchiectasis, but the levels of Ig and subclasses of IgG did not present differences.

conclusionsSteroid-dependent asthma seems to be associated with a greater risk of developing bronchiectasis than non-steroid-dependent asthma. This is probably due to the disease itself rather than to other influencing factors such as immunoglobulin levels.

Indexed as

Administration, OralAdrenal Cortex HormonesAdultAgedAsthmaBronchiectasisCase-Control StudiesCross-Sectional StudiesFemaleHumansImmunoglobulin GMaleMiddle AgedPrevalenceAdrenal Cortex HormonesImmunoglobulin G

Identifiers

PMID24324951
PMCPMC3845843
OpenAlexW2027729802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.